Pharmacodynamics of norepinephrine reuptake inhibition: Modeling the peripheral and central effects of atomoxetine, duloxetine, and edivoxetine on the biomarker 3,4-dihydroxyphenylglycol in humans

A pharmacokinetic/pharmacodynamic investigation: Assessment of edivoxetine and atomoxetine on systemic and central 3,4-dihydroxyphenylglycol, a biochemical marker for norepinephrine transporter inhibition

(2015) William Kielbasa et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Clinical Outcomes from an Open-Label Study of Edivoxetine Use in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder

(2013) Ling Jin et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Evaluation of the Effects of Duloxetine and Escitalopram on 24-Hour Heart Rate Variability

(2013) Jill C. Chappell et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Pharmacokinetics and Pharmacodynamics of Edivoxetine (LY2216684), a Norepinephrine Reuptake Inhibitor, in Pediatric Patients with Attention-Deficit/ Hyperactivity Disorder

(2012) William Kielbasa et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Duloxetine

(2011) Mary Pat Knadler et al.   CLINICAL PHARMACOKINETICS

A randomized, double-blind study comparing LY2216684 and placebo in the treatment of major depressive disorder

(2011) Beth Pangallo et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Changes of Urine Dihydroxyphenylglycol to Norepinephrine Ratio in Children With Attention-Deficit Hyperactivity Disorder (ADHD) Treated With Atomoxetine

(2010) Alonso Montoya et al.   JOURNAL OF CHILD NEUROLOGY

Short-term heart rate variability and cardiac norepinephrine spillover in patients with depression and panic disorder

(2009) Mathias Baumert et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Population Pharmacokinetics of Orally Administered Duloxetine in Patients

(2009) Evelyn D. Lobo et al.   CLINICAL PHARMACOKINETICS

Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine

(2009) Madhukar H. Trivedi et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

A study of the effects of LY2216684, a selective norepinephrine reuptake inhibitor, in the treatment of major depression

(2009) Sanjay Dubé et al.   JOURNAL OF PSYCHIATRIC RESEARCH